FDA Approves Abbott Laboratories’ Insulin-monitoring AppNovember 21st, 2018
QBC Capillary Centrifuge - An Ultra-compact Device for Rapid Hematology TestingNovember 19th, 2018
MEDICA 2018 - World Forum for Medicine
Düsseldorf, GermanyBooth No.: 3/D35-2
AACC Annual Scientific Meeting and Clinical Lab Expo
ChicagoBooth No.: 3849
Thanks to Block Scientific, I was able to procure the re-certified Bayer DCA 2000+ without hassles and get the lab back in operation. The
device works perfectly and I look forward to doing more business with Block Scientific.
--- Mathew Anderson, New Jersey
The DRG Prolactin ELISA is an enzyme immunoassay for the quantitative in vitro diagnostic measurement of Prolactin in serum.
Human prolactin (lactogenic hormone) is secreted from the anterior pituitary gland in both men and women (1). Human prolactin is a single chain polypeptide hormone with a molecular weight of approximately 23.000 daltons (2). The release and synthesis of prolactin is under neuroendocrinal control, primarily through Prolactin Releasing Factor and Prolactin Inhibiting Factor (3).
Women normally have slightly higher basal prolactin levels than men; apparently, there is an estrogen- related rise at puberty and a corresponding decrease at menopause. The primary functions of prolactin are to initiate breast development and to maintain lactation. Prolactin also suppresses gonadal function (4,5).
During pregnancy, prolactin levels increase progressively to between 10 and 20 times normal values, declining to nonpregnant levels by 3-4 weeks post- partum (4). Breast feeding mothers maintain high levels of prolactin, and it may take several months for serum concentrations to return to non-pregnant levels (3,4). The determination of prolactin concentration is helpful in diagnosing hypothalamic- pituitary disorders (3,4). Microadenomas (small pituitary tumors) may cause hyperprolactinemia, which is sometimes associated with male impotence (6). High prolactin levels are commonly associated with galactorrhea and amenorrhea.
Prolactin concentrations have been shown to be increased by estrogens, thyrotropin- releasing hormone (TRH), and several drugs affecting dopaminergic mechanisms (7,8,9,10). Prolactin levels are elevated in renal disease and hypothyroidism, and in some situations of stress, exercise, and hypoglycemia. Additionally, the release of prolactin is episodic and demonstrates diurnal variation (11). Mildly elevated prolactin concentrations should be evaluated taking these considerations into account. Prolactin concentrations may also be increased by drugs such as chloropromazine and reserpine, and may be lowered by bromocyptine and L-dopa (12).
The DRG Prolactin ELISA provides a rapid, sensitive, and a reliable assay. The antibodies developed for the test will determine a minimal concentration of human prolactin of 0.35 ng/mL. There is no cross-reactivity with hCG, TSH, LH, FSH, or hGH.